| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $147.2M | +17.2% |
| R&D Expense | $195.8M | -39.3% |
| SG&A Expense | $159.1M | -25.6% |
| Operating Income | -$562.2M | +74.3% |
| Pre-tax Income | -$534.5M | +75.3% |
| Income Tax | -$126.2M | +6.8% |
| Net Income | -$408.4M | +79.9% |
| EPS (Basic) | -$11.11 | +82.5% |
| EPS (Diluted) | -$11.11 | +82.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $249.7M | +16.6% |
| Accounts Receivable | $18.3M | -9.9% |
| Current Assets | $953.8M | +16.3% |
| Total Assets | $2.92B | -2.1% |
| Current Liabilities | $79.7M | +3.6% |
| Total Liabilities | $344.2M | -28.3% |
| Stockholders' Equity | $2.58B | +3.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$299.0M | +48.2% |
| Capital Expenditures | $909K | -82.5% |
| Investing Cash Flow | -$85.0M | +84.6% |
| Financing Cash Flow | $423.3M | -66.0% |
| Free Cash Flow | -$299.9M | +48.5% |